Latest Logos Global Management LP Stock Portfolio
$1.24Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Logos Global Management LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Logos Global Management LP reported an equity portfolio of $1.2 Billions as of 31 Mar, 2024.
The top stock holdings of Logos Global Management LP are IDYA, IMCR, IMVT. The fund has invested 5.3% of it's portfolio in IDEAYA BIOSCIENCES INC and 4.7% of portfolio in IMMUNOCORE HLDGS PLC.
The fund managers got completely rid off ARGENX SE (ARGX), RAYZEBIO INC and AMBRX BIOPHARMA INC (AMAM) stocks. They significantly reduced their stock positions in CYTOKINETICS INC (CYTK), TOURMALINE BIO INC and COMPASS PATHWAYS PLC (CMPS). Logos Global Management LP opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), GERON CORP (GERN) and CELLDEX THERAPEUTICS INC NEW (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, SILENCE THERAPEUTICS PLC (SLN) and ASTRIA THERAPEUTICS INC (ATXS).
The top stock holdings of Logos Global Management LP are IDYA, IMCR, IMVT. The fund has invested 5.3% of it's portfolio in IDEAYA BIOSCIENCES INC and 4.7% of portfolio in IMMUNOCORE HLDGS PLC.
The fund managers got completely rid off ARGENX SE (ARGX), RAYZEBIO INC and AMBRX BIOPHARMA INC (AMAM) stocks. They significantly reduced their stock positions in CYTOKINETICS INC (CYTK), TOURMALINE BIO INC and COMPASS PATHWAYS PLC (CMPS). Logos Global Management LP opened new stock positions in SAREPTA THERAPEUTICS INC (SRPT), GERON CORP (GERN) and CELLDEX THERAPEUTICS INC NEW (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to ENLIVEN THERAPEUTICS INC, SILENCE THERAPEUTICS PLC (SLN) and ASTRIA THERAPEUTICS INC (ATXS).
New Buys
| Ticker | $ Bought |
|---|---|
| SAREPTA THERAPEUTICS INC | 51,784,000 |
| GERON CORP | 29,700,000 |
| CELLDEX THERAPEUTICS INC NEW | 27,280,500 |
| VERA THERAPEUTICS INC | 24,794,000 |
| ADVERUM BIOTECHNOLOGIES INC | 21,210,000 |
| CYBIN INC | 16,540,000 |
| XENCOR INC | 14,384,500 |
| CG ONCOLOGY INC | 13,170,000 |
New stocks bought by Logos Global Management LP
Additions
| Ticker | % Inc. |
|---|---|
| ENLIVEN THERAPEUTICS INC | 412 |
| SILENCE THERAPEUTICS PLC | 269 |
| ASTRIA THERAPEUTICS INC | 128 |
| IMMUNOCORE HLDGS PLC | 125 |
| SPYRE THERAPEUTICS INC | 66.67 |
| IMMUNOVANT INC | 47.92 |
| OCULAR THERAPEUTIX INC | 45.29 |
| VIRIDIAN THERAPEUTICS INC | 16.67 |
Additions to existing portfolio by Logos Global Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| CYTOKINETICS INC | -93.85 |
| TOURMALINE BIO INC | -65.11 |
| COMPASS PATHWAYS PLC | -48.4 |
| ATYR PHARMA INC | -47.01 |
| ANNEXON INC | -38.38 |
| STRUCTURE THERAPEUTICS INC | -32.71 |
| APPLIED THERAPEUTICS INC | -18.67 |
| IDEAYA BIOSCIENCES INC | -16.67 |
Logos Global Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| AMBRX BIOPHARMA INC | -29,904,000 |
| VENTYX BIOSCIENCES INC | -4,940,000 |
| ACELYRIN INC | -9,325,000 |
| EDGEWISE THERAPEUTICS INC | -10,393,000 |
| AVIDITY BIOSCIENCES INC | -7,013,750 |
| REPARE THERAPEUTICS INC | -4,380,000 |
| RAYZEBIO INC | -35,323,300 |
| REVOLUTION MEDICINES INC | -10,038,000 |
Logos Global Management LP got rid off the above stocks
Current Stock Holdings of Logos Global Management LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ADVM | ADVERUM BIOTECHNOLOGIES INC | 1.72 | 1,500,000 | 21,210,000 | NEW | ||
| AGLE | SPYRE THERAPEUTICS INC | 0.77 | 250,000 | 9,482,500 | ADDED | 66.67 | |
| AKRO | AKERO THERAPEUTICS INC | 1.64 | 800,000 | 20,208,000 | UNCHANGED | 0.00 | |
| ALLK | ALLAKOS INC | 0.30 | 2,900,000 | 3,654,000 | UNCHANGED | 0.00 | |
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ANNX | ANNEXON INC | 1.77 | 3,050,000 | 21,868,500 | REDUCED | -38.38 | |
| APLS | APELLIS PHARMACEUTICALS INC | 3.81 | 800,000 | 47,024,000 | REDUCED | -15.79 | |
| APLT | APPLIED THERAPEUTICS INC | 0.73 | 1,350,000 | 8,976,000 | REDUCED | -18.67 | |
| ARGX | ARGENX SE | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ATXS | ASTRIA THERAPEUTICS INC | 1.42 | 1,244,960 | 17,522,800 | ADDED | 128 | |
| CGEM | CULLINAN ONCOLOGY INC | 0.96 | 700,000 | 11,928,000 | NEW | ||
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2.21 | 650,000 | 27,280,500 | NEW | ||
| CMPS | COMPASS PATHWAYS PLC | 0.15 | 257,980 | 1,813,600 | REDUCED | -48.4 | |
| CYBN | CYBIN INC | 1.34 | 40,000,000 | 16,540,000 | NEW | ||
| CYTK | CYTOKINETICS INC | 0.57 | 100,000 | 7,011,000 | REDUCED | -93.85 | |
| DCTH | DELCATH SYS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| DSGN | DESIGN THERAPEUTICS INC | 1.64 | 5,032,500 | 20,281,000 | UNCHANGED | 0.00 | |
| DYN | DYNE THERAPEUTICS INC | 3.98 | 1,730,000 | 49,114,700 | REDUCED | -7.98 | |
| ELEV | ELEVATION ONCOLOGY INC | 0.42 | 1,000,000 | 5,130,000 | NEW | ||
| EWTX | EDGEWISE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GERN | GERON CORP | 2.40 | 9,000,000 | 29,700,000 | NEW | ||
| ICVX | ICOSAVAX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IDYA | IDEAYA BIOSCIENCES INC | 5.33 | 1,500,000 | 65,820,000 | REDUCED | -16.67 | |
| IMCR | IMMUNOCORE HLDGS PLC | 4.74 | 900,000 | 58,500,000 | ADDED | 125 | |
| IMTX | IMMATICS N.V | 0.85 | 1,000,000 | 10,510,000 | NEW | ||
| IMUX | IMMUNIC INC | 0.04 | 421,184 | 555,963 | UNCHANGED | 0.00 | |
| IMVT | IMMUNOVANT INC | 4.64 | 1,775,000 | 57,350,200 | ADDED | 47.92 | |
| INBX | INHIBRX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IOBT | IO BIOTECH INC | 0.07 | 493,827 | 854,321 | UNCHANGED | 0.00 | |
| JANX | JANUX THERAPEUTICS INC | 0.46 | 150,000 | 5,647,500 | NEW | ||
| KNSA | KINIKSA PHARMACEUTICALS LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KRTX | KARUNA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KURA | KURA ONCOLOGY INC | 0.52 | 300,000 | 6,399,000 | NEW | ||
| LCTX | LINEAGE CELL THERAPEUTICS IN | 0.75 | 6,250,000 | 9,250,000 | NEW | ||
| LIFE | ATYR PHARMA INC | 0.49 | 3,100,000 | 6,045,000 | REDUCED | -47.01 | |
| LPTX | LEAP THERAPEUTICS INC | 0.01 | 39,500 | 105,070 | NEW | ||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MORF | MORPHIC HLDG INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NUVB | NUVATION BIO INC | 0.00 | 66,666 | 22,743 | UNCHANGED | 0.00 | |
| NXTC | NEXTCURE INC | 0.35 | 1,925,000 | 4,292,750 | NEW | ||
| OCUL | OCULAR THERAPEUTIX INC | 4.21 | 5,811,440 | 51,991,600 | ADDED | 45.29 | |
| OLMA | OLEMA PHARMACEUTICALS INC | 4.02 | 4,383,880 | 49,625,500 | UNCHANGED | 0.00 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 0.74 | 150,000 | 9,153,000 | NEW | ||
| RCKT | ROCKET PHARMACEUTICALS INC | 2.84 | 1,300,000 | 35,022,000 | ADDED | 1.96 | |
| RCUS | ARCUS BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RNA | AVIDITY BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RPTX | REPARE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RVMD | REVOLUTION MEDICINES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SLN | SILENCE THERAPEUTICS PLC | 2.52 | 1,476,060 | 31,085,900 | ADDED | 269 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.67 | 350,000 | 8,330,000 | NEW | ||
| SRPT | SAREPTA THERAPEUTICS INC | 4.19 | 400,000 | 51,784,000 | NEW | ||
| TRVI | TREVI THERAPEUTICS INC | 0.61 | 2,200,000 | 7,590,000 | NEW | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | 0.24 | 3,469,930 | 3,010,860 | NEW | ||
| VERA | VERA THERAPEUTICS INC | 2.01 | 575,000 | 24,794,000 | NEW | ||
| VRDN | VIRIDIAN THERAPEUTICS INC | 0.99 | 700,000 | 12,257,000 | ADDED | 16.67 | |
| VTYX | VENTYX BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| XENE | XENON PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| XNCR | XENCOR INC | 1.16 | 650,000 | 14,384,500 | NEW | ||
| STRUCTURE THERAPEUTICS INC | 2.50 | 720,058 | 30,861,700 | REDUCED | -32.71 | ||
| ENLIVEN THERAPEUTICS INC | 2.14 | 1,574,220 | 26,408,400 | ADDED | 412 | ||
| CG ONCOLOGY INC | 1.07 | 300,000 | 13,170,000 | NEW | |||
| ENGENE HOLDINGS INC | 1.04 | 800,000 | 12,882,000 | NEW | |||
| KYVERNA THERAPEUTICS INC | 1.00 | 500,000 | 12,420,000 | NEW | |||
| NEUMORA THERAPEUTICS INC. | 0.50 | 382,345 | 6,193,030 | UNCHANGED | 0.00 | ||
| BOUNDLESS BIO INC | 0.23 | 200,000 | 2,850,000 | NEW | |||
| TOURMALINE BIO INC | 0.18 | 99,208 | 2,271,860 | REDUCED | -65.11 | ||
| ACELYRIN INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | ||
| RAYZEBIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |